AEQUOR Revenue and Competitors

Aequor -- pronounced Acorn without the "n" -- means "The Sea" in Latin. Aequor's Founder discovered new chemicals in the ocean that are more potent and less toxic than anything known to kill bacteria and fungi -- including the antimicrobial resistant (AMR) Superbugs. PRODUCTS: Our platform includes "green" chemicals and products containing them for B2B sales and licensing: --Available now: 25 specialty chemicals - EPA/TSCA-approved --ingredients for consumer products to replace harmful biocides --proprietary formulations - sprays, washes, paints, coatings, etc.: --treatments for improving algae and yeast biomass production processes up to 40% in half the time for biofuels and renewable co-products --surface cleaners --water treatments --Pending EPA/FIFRA approval: 30 antimicrobials that are "green" and non-toxic for products and treatments making antibacterial, antifungal, antibiofilm and antifouling claims --Pending FDA approval : 30 new drug candidates The NIH offered Aequor free pre-clinical trials for 4 of the new drug candidates if we can deliver to them half-kilo samples. The DOD offered the same for up to 5 new drug candidates. SERVICES Aequor offers microbial and biofilm testing services for third parties seeking to determine efficacy of their formulations, devices, etc. UNMATCHED EXPERTISE Aequor's Founder Cynthia Burzell, Ph.D. - Marine and Medical Microbiology -- is considered a pioneer in Biofilms. She lectures internationally and offers educational training programs on biofilm and its impacts on the costs and operational inefficiencies in agro-industry, consumer, and healthcare sectors. UNMATCHED MODEL Aequor is a resident company at JLabs San Diego, raised $1.2M cash and is a Woman Owned Small Business, eligible for 5% of government contracts. For our in-house and virtual management team and updates, see our website. For further information: Marilyn Bruno , CEO - mbruno@aequorinc.com